HUMAN LEUKOCYE ANTIGEN (HLA)-DQA AND DQB EPLET MISMATCHES AND DE NOVO DONOR-SPECIFIC ANTI-HLA-DQ ANTIBODY

S FIDLER1, L D’ORSOGNA1, A IRISH2, WH LIM3

1 Department of Clinical Immunology, Fiona Stanley Hospital, Perth; 2 Department of Renal Medicine, Fiona Stanley Hospital, Perth; 3 Department of Renal Medicine, Sir Charles Gairdner Hospital, Perth

Aim: To determine the association between HLA-DQA and DQB eplet mismatches and development of de novo donor-specific anti-HLA-DQ antibody (DQ-DSA).

Background: DQ-DSA is the most common de novo DSA occurring post-kidney transplantation, often associated with an increased risk of antibody-mediated rejection and premature allograft loss. Even though HLA-DQ comprises of DQA1 and DQB1 gene products, DQA1 is not routinely typed in donor kidney allocation.

Methods: High-resolution molecular typing at the HLA-DQ allele in a cohort of 264 donor/recipient pairs in Western Australia between 2003-07 was performed using Sanger sequencing technique, with eplet mismatches calculated using HLAMatchmaker. Association between eplet mismatches at the HLA-DQA and HLA-DQB alleles and de novo DQ-DSA with mean fluorescent intensity of >500 (Luminex) was examined using logistic regression. Accuracy of eplet mismatches at the HLA-DQA and HLA-DQB alleles in predicting DQ-DSA was determined by Receiver Operating Characteristics Area Under the curve (AUC).

Results: Of the 264 recipients, 60 (23%) developed class II DSA, with 44/60 (73%) being DQ-DSA. The median (25-75th quartiles) number of eplet mismatches at the HLA-DQA and DQB alleles were 5 (0-15) and 9 (1-13), respectively. Every 5 additional eplet mismatches at the HLA-DQA locus was associated with an adjusted odds ratio of 1.43 (95%CI 1.09-1.87), compared to 1.16 (95%CI 0.83-1.62) for HLA-DQB locus. AUC for HLA-DQA eplet mismatches in predicting DQ-DSA was higher compared to HLA-DQB eplet mismatches (0.69 vs. 0.65; p=0.23).

Conclusions: There is a stronger association between HLA-DQA eplet mismatches and development of DQ-DSA compared to HLA-DQB mismatches. This study suggests that donor/recipient HLA-DQA typing should be routinely performed prior to kidney transplantation.

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the conference.
/wp-content/uploads/2017/08/Conference-Design-400x400.png
© 2015 - 2016 Conference Design Pty Ltd